#USA #New York #Gross Law Firm #Lead Plaintiff #Replimune Group

Important Notice for Replimune Group Shareholders

The Gross Law Firm has issued a crucial notice to investors of Replimune Group, Inc. (NASDAQ: REPL), calling attention to an impending deadline for lead plaintiffs in a class action lawsuit, which is set for October 5, 2026. Shareholders who acquired shares within the specific class period are strongly encouraged to assess their eligibility for potential lead plaintiff appointment. Notably, being appointed as a lead plaintiff is not necessary for participating in any recovery from the case.

Class Period and Allegations

The designated class period spans from October 20, 2025, to April 10, 2026. The allegations against the defendants are centered on claims that they issued misleading statements and failed to disclose critical information regarding the submission of a Biologics License Application (BLA) to the FDA. Specifically, the complaints highlight the following concerns:

1. Defendants did not adequately address previously communicated study design concerns from the FDA related to their application.
2. The company submitted data from an early, unplanned analysis of the RP1-104 study, which included only 40 patients—a mere 10% of the originally planned 400 patients.
3. The shortcomings in both the RPL-001-16 and RP1-104 studies raised substantial doubts about the BLA's chances of approval from the FDA.
4. As a result of the above events, defendants’ optimistic statements regarding the company's business and operational outlook were deemed misleading and lacking a factual basis.

Need for Timely Registration

Shareholders who purchased shares during the defined period should act promptly to ensure their registration in this class action. By registering, they will be enrolled in a comprehensive portfolio monitoring service that provides updates throughout the case’s development. It is essential to emphasize that there is no cost to participate in this action, which aims to assist investors who have suffered losses due to the company’s alleged failure to disclose crucial information.

How to Register

To register as a shareholder for the ongoing case, investors can follow the link provided to submit their details: Registration Link. Given the looming October 5 deadline, it is advisable to complete this process without delay.

Commitment from The Gross Law Firm

The Gross Law Firm is recognized nationally for its legal work in class action lawsuits, consistently advocating for investors' rights. The firm is dedicated to holding corporations accountable for any unlawful business practices and ensuring that investors can recover losses caused by deceptive actions and omissions. Their goal is to maintain responsible corporate governance and to foster good business ethics.

Contact Information

For further inquiries, affected shareholders are encouraged to reach out directly to The Gross Law Firm at:

• - Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

As a reminder, prior outcomes do not guarantee future results. Shareholders are urged to stay informed and take the necessary actions to protect their investments during this legal process.